Study Analysis Shows That Eltrombopag Significantly Improves Platelet Count And Response Rates In Idiopathic Thrombocytopenic Purpura (ITP)
Mon, 26 Jun 2006 06:00 AM EST
... GlaxoSmithKline plc yesterday announced results from a global Phase II study of its investigational small molecule oral platelet growth factor, eltrombopag. [click link for full article] ...
Related Topics
- Idiopathic Thrombocytopenia Purpura
- Platelet Count
- Immune Thrombocytopenic Purpura (ITP)
- Thrombocytopenia
- Data Analysis
- Bleeding Disorders
- Platelet Function
- Disaster Response
- Red Count
- White Count
- CD4
- Blood Disorders
- Blood Cells
- Emergency Preparedness & Response
- Pollen
- Hemoglobin
- Autoimmune Thrombocytopenia Purpura
- Immune Thrombocytopenia Purpura
- Relaxation Response
- Semen Analysis

Not Signed In -


